Results 21 to 30 of about 74,283 (261)

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. [PDF]

, 2012
BACKGROUND: Cervical cancer is the leading cause of female cancer-related deaths in Tanzania. Vaccination against human papillomavirus (HPV) offers a new opportunity to control this disease.
Quentin, Wilm, Terris-Prestholt, Fern, Changalucha, John, Soteli, Selephina, Edmunds, W John, Hutubessy, Raymond, Ross, David A, Kapiga, Saidi, Hayes, Richard, Watson-Jones, Deborah   +9 more
core   +5 more sources

Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk?

Australian and New Zealand Journal of Public Health, 2014
Objective: To determine whether HPV vaccine coverage in 12–13‐year‐olds varies by geographical area, remoteness and ecological level indicators of socioeconomic status (SES).
Bianca Barbaro, Julia M.L. Brotherton
doaj   +1 more source

Human papillomavirus vaccination at the first opportunity: An overview

Human Vaccines & Immunotherapeutics, 2023
The Advisory Committee on Immunization Practices (ACIP) has recommended human papillomavirus (HPV) vaccination for adolescents in the United States since 2006.
Robert A. Bednarczyk, Noel T. Brewer, Melissa B. Gilkey, Sherri Zorn, Rebecca B. Perkins, Kristin Oliver, Debbie Saslow   +6 more
doaj   +1 more source

Prophylactic HPV vaccines [PDF]

Journal of Clinical Pathology, 2007
The HPV L1 VLP vaccines are immensely important developments in public health and the benefits that they promise are immense, offering the opportunity to prevent, in the long term, 80% of cervical cancers, 60% of vulval cancers and 80% of anal cancers in women. In the short to medium term they will prevent at least 90% of genital warts and have a major
openaire   +3 more sources

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [PDF]

, 2019
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a systematic review and meta-analysis of the population-level impact of vaccinating girls and women against human ...
\uc9lodie, B\ue9nard, A Kahn, Jessica, A Machalek, Dorothy, A Smith, Megan, Ali, Hammad, Baldo, Vincenzo, Boily, MarcMarie\uadClaude, Brassard, Paul, Brisson,, Callander, Denton, Checchi, Marta, Cocchio, Silvia, Dalianis, Tina, Dehlendorff, Christian, Donovan, Basil, F Chow, Eric P, G Pollock, Kevin, Gr\ufcn, Nathalie, Harrison, Christopher, Herweijer, Eva, J Woestenberg, Petra, Jes\ufas Purri\uf1os\uadHermida, Mar\ueda, K Fairley, Christopher, K Kjaer, Susanne, Kavanagh, Kimberley, L Brotherton, Julia M, L Deeks, Shelley, Liu, Bette, M Garland, Suzanne, M Imburgia, Teresa, M Johnson, Anne, M Wheeler, Cosette, M\ue9lanie, Drolet, Markowitz, Lauri, Mesher, David, Munk, Christian, Niccolai, Linda, Norma, P\ue9rez, Nyg\ue5rd, Mari, Ogilvie, Gina, Oliphant, Jeannie, S\uf6derlund\uadStrand, Anna, Sonnenberg, Pam, Sparen, P\ue4r, Steben, Marc, T Hansen, Bo, Tanton, Clare, V Kliewer, Erich, W Flagg, Elaine, W Gargano, Julia, Yu., Bo Nancy   +50 more
core   +2 more sources

Measuring HPV vaccination coverage in Australia: comparing two alternative population‐based denominators

Australian and New Zealand Journal of Public Health, 2015
Objective: To compare the use of two alternative population‐based denominators in calculating HPV vaccine coverage in Australia by age groups, jurisdiction and remoteness areas. Method: Data from the National HPV Vaccination Program Register (NHVPR) were
Bianca Barbaro, Julia M.L. Brotherton
doaj   +1 more source

Availability of the HPV Vaccine in Regional Pharmacies and Provider Perceptions Regarding HPV Vaccination in the Pharmacy Setting

Vaccines, 2022
There is increasing support for HPV vaccination in the pharmacy setting, but the availability of the HPV vaccine is not well known. Additionally, little is known about perceptions of medical providers regarding referring patients to community pharmacies ...
Jill M. Maples, Nikki B. Zite, Oluwafemifola Oyedeji, Shauntá M. Chamberlin, Alicia M. Mastronardi, Samantha Gregory, Justin D. Gatwood, Kenneth C. Hohmeier, Mary E. Booker, Jamie D. Perry, Heather K. Moss, Larry C. Kilgore   +11 more
doaj   +1 more source

Predicting optimal impact interventions in the post-HPV vaccination world. [PDF]

Int J Cancer
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Lehtinen M, Lipsitch M, Pimenoff VN, Sundström K, Berkhof J, Baussano I, Vänskä S, Dillner J.   +7 more
europepmc   +2 more sources

Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives [PDF]

, 2018
Background: Primary care practitioners (PCP) play key roles in cervical cancer prevention. Human papillomavirus (HPV) knowledge is an important influence on PCPs’ cervical cancer prevention-related behaviours.
ATHENS (A Trial of HPV Education and Support) Group, Cara M Martin, Eamonn O'Leary, Jill J Francis, John J O'Leary, Linda Sharp, Lisa A McSherry, Stephan U Dombrowski   +7 more
core   +5 more sources

Evaluation of the burden of HPV-related hospitalizations as a useful tool to increase awareness: 2007–2017 data from the sicilian hospital discharge records [PDF]

, 2020
In light of the implementation of human papillomavirus (HPV) prevention strategies, epidemiological studies in different geographical areas are required in order to assess the impact of HPV-related diseases.
Amato L., Amodio E., Candiloro S., Casuccio A., Costantino C., Maranto M., Marrella A., Palmeri S., Pizzo S., Restivo V., Vitale F.   +10 more
core   +1 more source